Skip to main content

Semax vs Cerebrolysin

Both Semax and Cerebrolysin are used for cognitive and neuroprotection. Here's how their evidence, dosing, and regulatory status actually compare.

Semax

Evidence B

Semax (MEHFPGP)

A synthetic ACTH fragment that increases BDNF levels and enhances focus, memory, and mental clarity. Delivered intranasally for rapid cognitive effects.

View full Semax profile →

Cerebrolysin

Evidence B

Cerebrolysin (porcine brain peptide complex)

A standardized mixture of low-molecular-weight peptides from porcine brain. Decades of stroke, dementia, and TBI trial data — modest but consistent cognitive recovery effects.

View full Cerebrolysin profile →

Side-by-Side

AttributeSemaxCerebrolysin
Evidence GradeBB
FDA StatusNot FDA-approved in US — approved in Russia for stroke and cognitive disordersNot FDA-approved in US — approved in 50+ countries for stroke, traumatic brain injury, and dementia
Typical Dose200–600 mcg intranasal, morningTrial range: 5–30 mL daily (intravenous infusion)
Clinics Indexed8941
Categoriescognitive, neuroprotectioncognitive, neuroprotection

Key reported benefits — Semax

  • BDNF increase
  • Enhanced focus
  • Memory improvement
  • Neuroprotection

Key reported benefits — Cerebrolysin

  • Stroke recovery support
  • TBI rehabilitation
  • Cognitive function in dementia

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons